Global Lupus Therapeutics Market to be Dominated by North America Region Through 2028
Increasing prevalence of
Lupus and rising research and development are expected to drive the Global
Lupus Therapeutics Market in the forecast period, 2024–2028.
According to TechSci Research report, “Lupus Therapeutics Market
- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028”. Global Lupus
Therapeutics Market is projected to increase at an impressive rate in the
forecast period, 2024-2028. Expanding healthcare industries and population
development, particularly in emerging economies, has raised the demand for
lupus therapeutics. Despite being a prevalent disease, lupus is often
misdiagnosed or undiagnosed, making it challenging to manage. However,
increased awareness and education of lupus have driven the global lupus
therapeutics market. Governments, healthcare organizations, and advocacy groups
have stepped up efforts to educate the public about lupus, its symptoms, and
how to manage it. These initiatives have led to more accurate diagnoses and
improved treatment options, thereby increasing demand for lupus therapeutics.
Moreover, pharmaceutical companies have also invested heavily in research and
development of lupus drugs. This has led to the introduction of new and
innovative drugs in the market, which has improved the quality of life of lupus
patients. This in turn is expected to create lucrative opportunities for the
growth of global lupus therapeutics market. Additionally, technological advancements in
healthcare have also contributed to the growth of the lupus therapeutics
market. For instance, the use of telemedicine and wearable devices has made it
easier for doctors to monitor patients remotely, improving the management of
lupus. Furthermore, artificial intelligence and big data analytics have enabled
doctors to personalize lupus treatment, thereby improving the efficacy of the
treatment and hence accelerated the uptake of these therapeutics. Thus,
propelling the growth of the overall global lupus therapeutics market.
One of the main
challenges hampering the growth of global lupus therapeutics market is the high
cost of drugs. Many of the new drugs for lupus are expensive, making them
difficult to access for many patients. Another challenge is the complexity of
the disease itself. Lupus can manifest in various ways, making it difficult to
diagnose and treat effectively, thereby hampering the growth of global lupus
therapeutics market. Also lack of skilled healthcare professionals and limited
coverage may hamper the growth of global lupus therapeutics market.
Browse over XX market
data Figures spread through 110 Pages and an in-depth TOC on "Lupus Therapeutics Market.”
Global Lupus Therapeutics is
segmented based on Treatment Type, Route of Administration and End-User.
Based on treatment type, the global lupus therapeutics market is divided
into NSAIDs, corticosteroids, antimalarials,
immunosuppressants, biologics and others. The segment antimalarial drug is expected to witness a rise over
the forecast period. This is attributed to the fact that in particular,
anti-malarial drugs have been shown to lessen fatigue and fever caused by
lupus, muscle and joint pain, skin rashes, pericarditis, and pleuritis
(inflammation of the lining of the lung). These drugs may also stop the spread
of lupus to specific organs like the kidney and central nervous system.
Anti-malarial drugs reduce the symptoms of lupus by
modulating the immune system without increasing your risk of infection.
Anti-malarial medications can shield the skin from UV rays and occasionally even
treat skin lesions that don't respond to topical (ointment) therapy. The immune
system's plasmacytoid dendritic cells, which are in charge of producing
interferon, may not activate in response to anti-malarial drugs.
Based on route of administration, the global lupus therapeutics market is
divided into oral, intravenous and
subcutaneous. The segment oral route of administration is expected to witness a rise
over the forecast period. This is attributed to its convenience and
cost-effectiveness and is widely adopted as a route of drug administration.
Based on end-user, the global lupus therapeutics market is divided into hospitals & clinics, ambulatory care centers and others. The hospitals & clinics segment is expected to witness a rise over
the forecast period. This is attributed to the facilities offered by hospitals
& clinics. All the inpatient and outpatient facilities are available under
one roof, which provides more convenience to the patients.
Major companies operating
in Global Lupus Therapeutics market
are:
- GlaxoSmithKline,
plc.
- Novartis AG
- AstraZeneca,
plc.
- F.
Hoffmann-La Roche AG
- Eli Lilly
and Company
- ImmuPharma
PLC
- Pfizer, Inc.
- Sanofi S.A.
- Bristl Myers
Squibb Company
- Merck &
Co., Inc.
Download Free Sample Report
Customers
can also request for 10% free customization on this report.
" North America is expected to dominate
the Global Lupus Therapeutics Market during the forecast period due to the
existence of significant market players, rising prevalence of lupus. Additionally,
improved healthcare infrastructure and increasing research and development by
collaborations of public and private firms are creating favorable conditions to
boost the global demand for Lupus Therapeutics till 2028. The increasing number
of clinical trials in the region especially in the United States to find a cure
for the disease is expected to support the growth of lupus therapeutics market
in the region” said Mr. Karan Chechi, Research Director with TechSci Research,
a research-based global management consulting firm.
“Lupus
Therapeutics Market, 2028 - Global Industry Size, Share, Trends, Opportunity,
and Forecast, 2018-2028 Segmented By Treatment Type (NSAIDs,
Corticosteroids, Antimalarials, Immunosuppressants, Biologics, Others), By
Route of Administration (Oral, Intravenous, Subcutaneous), By End User (Hospitals
& Clinics, Ambulatory Care Centers, Others), By Region, By Competition, has evaluated the future growth potential of Global Lupus
Therapeutics and provides statistics & information on market size,
structure, and future market growth. The report intends to provide cutting-edge
market intelligence and help decision makers take sound investment decisions.
Besides, the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in Global Lupus Therapeutics market.”
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com